Kinetic mechanism of time-dependent inhibition of CYP2D6 by 3,4-methylenedioxymethamphetamine (MDMA): Functional heterogeneity of the enzyme and the reversibility of its inactivation

Biochem Pharmacol. 2018 Oct:156:86-98. doi: 10.1016/j.bcp.2018.08.010. Epub 2018 Aug 13.

Abstract

We investigate the mechanism of time-dependent inhibition (TDI) of human cytochrome P450 2D6 (CYP2D6) by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), one of the most widespread recreational drugs of abuse. In an effort to unravel the kinetic mechanism of the formation of metabolic inhibitory complex (MIC) of CYP2D6 with MDMA-derived carbene we carried out a series of spectrophotometric studies paralleled with registration of the kinetics of time-dependent inhibition (TDI) in CYP2D6-incorporated proteoliposomes. The high amplitude of spectral signal in this system allowed us to characterize the spectral properties of the formed MIC in details and obtain an accurate spectral signature of MIC formation. This information was then used in the studies with CYP2D6-containing microsomes of insect cells (CYP2D6 Supersomes™). Our results demonstrate that in both systems the formation of the ferrous carbene-derived MIC is relatively slow, reversible and is not associated with the accumulation of the ferric carbene intermediate, as takes place in the case of CYP3A4 and podophylotoxin. Furthermore, the limited amplitude of MIC formation suggests that only a fraction (∼50%) of spectrally detectable CYP2D6 in both proteoliposomes and Supersomes participates in the formation of MIC and is therefore involved in the MDMA metabolism. This observation reveals yet another example of a cytochrome P450 that exhibits persistent functional heterogeneity of its population in microsomal membranes. Our study provides a solid methodological background for further mechanistic studies of MIC formation in human liver microsomes and demonstrates that the potency and physiological relevance of MDMA-dependent TDI of CYP2D6 may be overestimated.

Keywords: 3,4-methylenedioxymethamphetamine; Cytochrome P450 2D6; Mechanism-based inhibition; Methylenedioxyphenyl compounds; Time-dependent inhibition.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cytochrome P-450 CYP2D6 / metabolism*
  • Cytochrome P-450 CYP2D6 Inhibitors / pharmacology*
  • Dextromethorphan / metabolism
  • Dextromethorphan / pharmacology
  • Gene Expression Regulation, Enzymologic / drug effects
  • Humans
  • Kinetics
  • Molecular Structure
  • N-Methyl-3,4-methylenedioxyamphetamine / chemistry
  • N-Methyl-3,4-methylenedioxyamphetamine / pharmacology*
  • Serotonin Agents / pharmacology*

Substances

  • Cytochrome P-450 CYP2D6 Inhibitors
  • Serotonin Agents
  • Dextromethorphan
  • Cytochrome P-450 CYP2D6
  • N-Methyl-3,4-methylenedioxyamphetamine